A venture firm with offices in Europe and Asia invests in life science companies in the Benelux region, Germany, France, and parts of Asia, all near where the firm has operations. The firm may invest up to EUR 10 million in early stage venture rounds as well as clinical stage opportunities.
The firm invests in the prevention and treatment of chronic diseases. In terms of sector, the firm makes investments in therapeutics, medtech and digital health and diagnostics. Generally the firm invests in assets that are close to IND or close to registration for first in human trials.
The firm is interested in opportunities with a driven entrepreneurial team, good IP protection, which are addressing important medical needs.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply